Use of the Newer Immunosuppressive Agents in Dermatology

Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis

Scott Gottlieb, Patricia Gilleaudeau, Ray A. Johnson et al. · Nature Medicine · 1995 · 614 citations

Medicine, Dermatology, Immunology +16

DOUBLE-MASKED TRIAL OF CYCLOSPORIN VERSUS COLCHICINE AND LONG-TERM OPEN STUDY OF CYCLOSPORIN IN BEHÇET'S DISEASE

Kanjiro Masuda, M Kogure, Akira Nakajima et al. · The Lancet · 1989 · 489 citations

Life Sciences, Immunology, Clinical Immunology +5

Cyclosporine for Plaque-Type Psoriasis

Charles N. Ellis, Mark S. Fradin, Joseph M. Messana et al. · New England Journal of Medicine · 1991 · 432 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +6

Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis

J. M. Sowden, B.R. Allen, J. Berth‐Jones et al. · The Lancet · 1991 · 418 citations

Life Sciences, Dermatology, Immunology +14

Risk Factors for Cyclosporine-Induced Nephropathy in Patients with Autoimmune Diseases

G Feutren, Michael J. Mihatsch · New England Journal of Medicine · 1992 · 409 citations · Full text

Medicine, Nephrology, Pharmacology +14